✦ LIBER ✦

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide – a Southwest Oncology Group clinical and pharmacokinetic study

✍ Scribed by Steven M. Grunberg; John Crowley; Kenneth R. Hande; Dori Giroux; Nikhil Munshi; Derick H. M. Lau; Louis E. Schroder; Mark H. Zangmeister; Stanley P. Balcerzak; Harry E. Hynes; David R. Gandara

Publisher: Springer
Year: 1999
Tongue: English
Weight: 115 KB
Volume: 44
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051119

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of etoposide and cisplatin wi

Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study

✍ ROBERT M. O'Bryan; John J. Crowley; Paik N. Kim; Robert B. Epstein; Barbara Neil 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.